Aarti Pharmalabs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 6, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	63,074	39,418	24,999	-	-	-
Market Cap Growth	64.74%	57.68%	-	-	-	-
Enterprise Value	64,983	40,892	26,947	-	-	-
Last Close Price	696.10	434.24	274.34	-	-	-
PE Ratio	28.01	18.15	12.85	-	-	-
PS Ratio	3.24	2.13	1.29	-	-	-
PB Ratio	3.59	2.24	1.60	-	-	-
P/FCF Ratio	-	64.88	16.89	-	-	-
P/OCF Ratio	-	18.22	10.00	-	-	-
EV/Sales Ratio	3.33	2.21	1.39	-	-	-
EV/EBITDA Ratio	16.35	10.59	7.88	-	-	-
EV/EBIT Ratio	20.22	13.07	9.64	-	-	-
EV/FCF Ratio	-	67.31	18.21	-	-	-
Debt / Equity Ratio	0.16	0.16	0.14	0.25	0.08	0.08
Debt / EBITDA Ratio	0.72	0.74	0.63	1.65	-	-
Debt / FCF Ratio	-	4.70	1.45	-1.85	-	-1.00
Asset Turnover	-	0.77	0.91	1.18	-	-
Inventory Turnover	-	1.70	2.24	-	-	-
Quick Ratio	-	0.90	0.86	0.80	11.42	-
Current Ratio	-	1.94	1.94	1.77	11.42	-
Return on Equity (ROE)	-	13.08%	13.14%	17.63%	-2.00%	-
Return on Assets (ROA)	-	8.10%	8.16%	10.10%	-1.15%	-
Return on Capital (ROIC)	10.48%	10.25%	9.98%	11.92%	-1.16%	-
Earnings Yield	3.57%	5.50%	7.74%	-	-	-
FCF Yield	1.54%	5.92%	-	-	-
Dividend Yield	0.29%	0.69%	0.73%	-	-	-
Payout Ratio	0.00%	8.36%	9.37%	-	-	-
Buyback Yield / Dilution	-0.04%	-0.01%	-	-36150.40%	-	-
Total Shareholder Return	0.25%	0.68%	0.73%	-36150.40%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.